A team of BHU researchers conducted a one-year follow-up study on Bharat Biotech's Covaxin and found that almost one-third of the participants reported adverse events of special interest (AESI). Additionally, nearly half of the 926 participants complained of infections, mainly...
Keywords: Covaxin breaking, Covaxin latest, Covaxin latest, Covaxin after one year
Read More